Tencent and Legal & General co-led a series C round for genomic testing software provider Congenica that will fund the expansion of its partnership activities.
Congenica, a UK-based patient genomic testing service provider, closed a $50m series C round on Friday that was co-led by internet group Tencent and insurance provider Legal & General.
The round also featured Parkwalk Advisors, part of commercialisation firm IP Group, as well as Cambridge Innovation Capital (CIC), Xeraya Capital, Puhua Capital, IDO Investments and Downing Ventures.
Founded in 2014, Congenica produces genomic analysis software used by research labs to scrutinise genetic samples extracted from next-generation DNA sequencers.
The software…
